Concepedia

Michishige Terasaki

MT

Statistics

Publications

30

Citations

1.3K

H-Index

16

Active since

2010

Affiliations

SHOWA Medical University(Current)

Tokyo University of Pharmacy and Life Sciences

Ebina General Hospital

Kurume University

Karolinska Institutet

Michishige Terasaki is an author at SHOWA Medical University specializing in pharmacology, medicine, and diabetes mellitus.

ORCID

Publications per year

2010–2024

30

Publications

30

Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

Masaharu Nagashima, Takuya Watanabe, Michishige Terasaki et al. · Diabetologia · 2011 · 250 citations · Full text

, , +17

A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis

Yuko Tashiro, Kengo Sato, Takuya Watanabe et al. · Peptides · 2014 · 148 citations

, , +12

Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice

Michishige Terasaki, Munenori Hiromura, Yusaku Mori et al. · PLoS ONE · 2015 · 110 citations · Full text

, , +17

Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice

Yukinori Nogi, Masaharu Nagashima, Michishige Terasaki et al. · PLoS ONE · 2012 · 93 citations · Full text

, , +12

Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice

Michishige Terasaki, Masaharu Nagashima, Kyoko Nohtomi et al. · PLoS ONE · 2013 · 72 citations · Full text

, , +17

1–5 of 30